1. Davies AN, Dickman A, Reid C. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain. 2009;13(4):331–8.
2. Portenoy RK, Hagen NA. Breakthrough pain: definition and management. Oncology (Willison Park NY). 1989;3(8 Suppl):25–9.
3. Working Group Nientemale DEI, Vellucci R, Fanelli G, Pannuti R, Peruselli C, Adamo S, Alongi G, Amato F, Consoletti L, Lamarca L, Liguori S, Lo Presti C, Maione A, Mameli S, Marinangeli F, Marulli S, Minotti V, Miotti D, Montanari L, Moruzzi G, Palermo S, Parolini M, Poli P, Tirelli W2, Valle A, Romualdi P. What to do, and what not to do, when diagnosing and treating breakthrough cancer pain (BTcP). Expert Opin Drugs. 2016;76(3):315–30.
4. Lee TH. Zero pain is not the goal. JAMA. Published online March 15, 2016. doi: 10.1001/jama.2016.1912 .
5. Zeppetella G, Davies AN. Opioids for the management of breakthrough pain in cancer patients. In: Cochrane Database of Systematic Reviews. Wiley;2015. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004311.pub4/abstract . Accessed 21 Mar 2016.